Skip to content
logo acclivis group
  • About Us
  • News
  • Portfolio
  • Contact Us
Menu
  • About Us
  • News
  • Portfolio
  • Contact Us
mobile menu toggle

News

Loading...
News
June 22, 2023

Z Software and Medi-Map Announce Merger to Improve Community Health Outcomes

Z Software, a leading provider of community pharmacy and healthcare software solutions, and Medi-Map, a healthcare technology innovator specialising in medication management, today announced..

CONTINUE READING
News
June 22, 2023

Medi-Map adds single sign-on to meds management platform

Electronic medication management specialist Medi-Mep has released single sign-on (SSO) for its Medi-Map platforms in New Zealand and Australia.

CONTINUE READING
News
June 22, 2023

Pharmacy and meds management specialists Z Software and Medi-Map to merge

Sydney-based community pharmacy software vendor Z Software is merging with electronic medication management specialist Medi-Map.

CONTINUE READING
News
June 22, 2023

Acclivis Group takes a stake in DI exchange vendor Zed Technologies

Healthcare technology specialist investment firm Acclivis Group has acquired a majority stake in Australian diagnostic imaging exchange provider Zed Technologies.

CONTINUE READING
News
June 1, 2022

eHealthTALK NZ

Medtech Global managing director Geoff Sayer discusses their new online payment service Medeor Pay by Link and its benefits to both practices and patients.

CONTINUE READING
News
May 5, 2022

Medtech Medeor, Integrating Payments for General Practice in New Zealand

Customers and businesses alike expect seamless, contactless payments for purchases made everywhere from big retail to the coffee bought from the café on the corner. Despite the pandemic, this payment option has not existed for general medical practices and their patients in New Zealand.

CONTINUE READING
News
March 1, 2022

FHIR standards key to unlocking innovation for consumer health tech

In a first for Aotearoa, patients are now engaging with their primary care providers using a fully standards-based digital solution at scale. Utilising the HL7 FHIR® International Patient Summary (IPS), endorsed by standards governing body HISO, Centrik® paves the way for healthcare service providers to implement interoperable and integrated solutions in New Zealand and abroad.

CONTINUE READING
News
November 19, 2021

Medtech Evolution is Services Australia web services ready

Medtech Global, the provider of the Evolution General Practice Management Systems in Australia and New Zealand, is pleased to announce that Medtech Evolution (Australia) is web services ready after receiving their NOI (Notice of Integration) certification from Services Australia at the end of October 2021.

CONTINUE READING
News
November 15, 2021

PE calls for pharmacy software group Z Software

Specialist private equity investor Acclivis Group has recorded its maiden Australian buyout, snapping up pharmacy management software provider Z Software.

CONTINUE READING
News
September 1, 2021

Medtech has high hopes after buying DrInfo

Both applications will be much more seamless MEDTECH GLOBAL IS PROMISING better integration of its practice management systems with analytics too

CONTINUE READING
News
August 5, 2021

Case Study: Medtech Global

With around 85 percent market share, GP PMS solutions from Auckland-based Medtech Global, are the most widely used in primary care across New Zealand.

CONTINUE READING
News
August 4, 2021

Medtech buys population health and audit tool developer DrInfo

Practice management system vendor Medtech Global has acquired DrInfo, which markets a population health, audit and compliance tool used by over 50 per cent of New Zealand general practices.

CONTINUE READING
News
August 4, 2021

Medtech Global acquires population health and audit tool developer DrInfo

DrInfo supports several practice management system providers by delivering information on enrolments, capitation optimisation, population health targets, among others.

CONTINUE READING

No more pages to load

1 2 Next »

News

Loading...
News
June 22, 2023

Z Software and Medi-Map Announce Merger to Improve Community Health Outcomes

Z Software, a leading provider of community pharmacy and healthcare software solutions, and Medi-Map, a healthcare technology innovator specialising in medication management, today announced..

CONTINUE READING
News
June 22, 2023

Medi-Map adds single sign-on to meds management platform

Electronic medication management specialist Medi-Mep has released single sign-on (SSO) for its Medi-Map platforms in New Zealand and Australia.

CONTINUE READING
News
June 22, 2023

Pharmacy and meds management specialists Z Software and Medi-Map to merge

Sydney-based community pharmacy software vendor Z Software is merging with electronic medication management specialist Medi-Map.

CONTINUE READING
News
June 22, 2023

Acclivis Group takes a stake in DI exchange vendor Zed Technologies

Healthcare technology specialist investment firm Acclivis Group has acquired a majority stake in Australian diagnostic imaging exchange provider Zed Technologies.

CONTINUE READING
News
June 1, 2022

eHealthTALK NZ

Medtech Global managing director Geoff Sayer discusses their new online payment service Medeor Pay by Link and its benefits to both practices and patients.

CONTINUE READING
News
May 5, 2022

Medtech Medeor, Integrating Payments for General Practice in New Zealand

Customers and businesses alike expect seamless, contactless payments for purchases made everywhere from big retail to the coffee bought from the café on the corner. Despite the pandemic, this payment option has not existed for general medical practices and their patients in New Zealand.

CONTINUE READING
News
March 1, 2022

FHIR standards key to unlocking innovation for consumer health tech

In a first for Aotearoa, patients are now engaging with their primary care providers using a fully standards-based digital solution at scale. Utilising the HL7 FHIR® International Patient Summary (IPS), endorsed by standards governing body HISO, Centrik® paves the way for healthcare service providers to implement interoperable and integrated solutions in New Zealand and abroad.

CONTINUE READING

No more pages to load

1 2 3 Next »
logo acclivis group

Acclivis Group is a private investment and advisory firm exclusively focused on healthcare software and technology companies.

CONTINUE READING
CONTACT US
Linkedin-in
Site map
  • Home
  • About us
  • Portfolio
  • News
  • Contact us
  • Disclaimer
Contact
  • info@acclivis.group
©2025 Acclivis Group. All rights reserved.
  • MADE WITH
  • BY DIGITAL RECIPE

Acclivis Group Management Pty Ltd (CAR) is a corporate authorised representative of Boutique Capital Pty Ltd (BCPL) AFSL 508011, CAR Number 001293067. CAR is the investment manager of the Acclivis Investment I Fund (Fund).

To the extent to which this document contains advice it is general advice only and has been prepared by the CAR for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth).

The information herein is presented in summary form and is therefore subject to qualification and further explanation. The information in this document is not intended to be relied upon as advice to investors or potential investors and has been prepared without taking into account personal investment objectives, financial circumstances or particular needs. Recipients of this document are advised to consult their own professional advisers about legal, tax, financial or other matters relevant to the suitability of this information.

The investment summarised in this document is subject to known and unknown risks, some of which are beyond the control of CAR and their directors, employees, advisers or agents. CAR does not guarantee any particular rate of return or the performance of the Fund, nor does CAR and its directors personally guarantee the repayment of capital or any particular tax treatment. Past performance is not indicative of future performance.

The materials contained herein represent a general summary of CAR’s current portfolio construction approach. CAR is not constrained with respect to any investment decision making methodologies and may vary from them materially at its sole discretion and without prior notice to investors. Depending on market conditions and trends , CAR may pursue other objectives or strategies considered appropriate and in the best interest of portfolio performance.

There are risks involved in investing in the CAR’s strategy. All investments carry some level of risk, and there is typically a direct relationship between risk and return. We describe what steps we take to mitigate risk (where possible) in the Fund’s Information Memorandum. It is important to note that despite taking such steps, the CAR cannot mitigate risk completely.

This document was prepared as a private communication to clients and is not intended for public circulation or publication or for the use of any third party, without the approval of CAR. Whilst this report is based on information from sources which CAR considers reliable, its accuracy and completeness cannot be guaranteed. Data is not necessarily audited or independently verified. Any opinions reflect CAR’s judgment at this date and are subject to change. CAR has no obligation to provide revised assessments in the event of changed circumstances. To the extent permitted by law, BCPL, CAR and their directors and employees do not accept any liability for the results of any actions taken or not taken on the basis of information in this report, or for any negligent misstatements, errors or omissions.

This Document is informational purposes only and is not a solicitation for units in the Fund. Application for units in the Fund can only be made via the Fund’s Information Memorandum and Application Form.

white site icon
  • About Us
  • News
  • Portfolio
  • Contact Us
  • About Us
  • News
  • Portfolio
  • Contact Us
  • info@acclivis.group